Terns Pharmaceuticals Inc (TERN)

10:32 AM

Terns Pharmaceuticals stock price target raised to $22 at BMO on strong ASH data - Investing.com Nigeria

10:32 AM

10:31 AM

Terns Pharmaceuticals stock extends gain after positive CML drug data - Investing.com

10:31 AM

10:04 AM

Terns Pharmaceuticals stock hits 52-week high at 16.41 USD - Investing.com

10:04 AM

09:39 AM

Terns Pharma (TERN): Barclays Raises Price Target by 92.86% | TE - GuruFocus

09:39 AM

08:54 AM

Mizuho Boosts Price Target on Terns Pharmaceuticals to $32 From $9, Keeps Outperform Rating - MarketScreener

08:54 AM

08:45 AM

Terns reports 64% MMR rate in phase 1 CML trial with TERN-701 - Investing.com Australia

08:45 AM

08:07 AM

Terns Pharmaceuticals (TERN) Upgraded with Increased Price Target Following Promising Data - GuruFocus

08:07 AM

08:03 AM

Terns Pharmaceuticals stock rating upgraded to Buy by H.C. Wainwright - Investing.com

08:03 AM

07:57 AM

Terns Pharma (TERN) Upgraded to Buy by HC Wainwright & Co. | TER - GuruFocus

07:57 AM

07:40 AM

Terns Pharmaceuticals stock price target raised by Truist on CML drug data - Investing.com South Africa

07:40 AM

05:34 AM

Price momentum metrics for Terns Pharmaceuticals Inc. explainedEarnings Risk Report & AI Powered Trade Plan Recommendations - newser.com

05:34 AM

03:37 AM

Relative strength of Terns Pharmaceuticals Inc. in sector analysisMarket Performance Recap & Weekly Return Optimization Alerts - newser.com

03:37 AM

03:13 AM

Terns Pharmaceuticals (TERN) Is Up 74.1% After Positive Phase 1 TERN-701 Data in CML Patients - Yahoo Finance

03:13 AM

03:03 AM

Combining price and volume data for Terns Pharmaceuticals Inc.Dollar Strength & Growth Oriented Trade Recommendations - newser.com

03:03 AM

02:45 AM

How sentiment analysis helps forecast Terns Pharmaceuticals Inc.Quarterly Growth Report & Verified Short-Term Trading Plans - newser.com

02:45 AM

12:32 PM

Terns Pharmaceuticals (TERN) Pivots After TERN-601 Setback Can a Focus on Oncology Redefine Its Future? - simplywall.st

12:32 PM

Nov 03, 2025

After GLP-1 drug falters, Terns Pharmaceuticals shifts focus to cancerBizwomen - The Business Journals

Nov 03, 2025

Nov 03, 2025

Terns Pharma (TERN) Upgraded to Outperform by William Blair | TE - GuruFocus

Nov 03, 2025

Nov 03, 2025

Oppenheimer raises Terns Pharmaceuticals stock price target to $24 on promising leukemia drug data - Investing.com Australia

Nov 03, 2025

Nov 03, 2025

William Blair upgrades Terns Pharmaceuticals stock rating to Outperform By Investing.com - Investing.com Australia

Nov 03, 2025

Nov 03, 2025

Biotech Deals And Breakthroughs Spark Heavy Trading Across Markets - Finimize

Nov 03, 2025

Nov 03, 2025

Pharmaceutical Stocks To Add to Your WatchlistNovember 3rd - MarketBeat

Nov 03, 2025

Nov 03, 2025

Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades - Benzinga

Nov 03, 2025

Nov 03, 2025

Terns reports 64% MMR rate in phase 1 CML trial with TERN-701 By Investing.com - Investing.com South Africa

Nov 03, 2025

Nov 03, 2025

William Blair upgrades Terns Pharmaceuticals stock rating to Outperform - Investing.com

Nov 03, 2025

Nov 03, 2025

Terns Pharmaceuticals (TERN) Upgraded After Promising Clinical T - GuruFocus

Nov 03, 2025

Nov 03, 2025

Terns Pharmaceuticals stock soars on promising data for CML therapy By Investing.com - Investing.com Philippines

Nov 03, 2025

Nov 03, 2025

Terns Pharmaceuticals (TERN) Presents Promising Data from CARDINAL Trial - GuruFocus

Nov 03, 2025

Nov 03, 2025

Terns Pharmaceuticals stock soars on promising data for CML therapy - Investing.com

Nov 03, 2025

Nov 03, 2025

Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting - The Manila Times

Nov 03, 2025

Nov 03, 2025

Terns Pharmaceuticals Announces Positive Data from CARDINAL Trial - TradingView

Nov 03, 2025

Nov 03, 2025

Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML ... - Bluefield Daily Telegraph

Nov 03, 2025

Nov 03, 2025

Will Terns Pharmaceuticals Inc. stock recover after recent dropPortfolio Return Report & Consistent Profit Trade Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Sector ETF performance correlation with Terns Pharmaceuticals Inc.Trade Entry Summary & Low Risk Entry Point Tips - newser.com

Nov 03, 2025

Nov 03, 2025

Applying Wyckoff theory to Terns Pharmaceuticals Inc. stockMarket Trend Review & High Conviction Buy Zone Picks - newser.com

Nov 03, 2025

Nov 03, 2025

Should you hold or exit Terns Pharmaceuticals Inc. nowTrade Ideas & Intraday High Probability Setup Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Real time breakdown of Terns Pharmaceuticals Inc. stock performanceQuarterly Performance Summary & Target Return Focused Stock Picks - newser.com

Nov 03, 2025

Nov 03, 2025

How hedge fund analytics apply to Terns Pharmaceuticals Inc. stockWeekly Investment Report & Long-Term Safe Return Strategies - newser.com

Nov 03, 2025

Nov 03, 2025

Is Terns Pharmaceuticals Inc. still worth holding after the dipJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com

Nov 03, 2025

Nov 02, 2025

How Terns Pharmaceuticals Inc. stock reacts to Fed rate cutsMarket Sentiment Review & Technical Entry and Exit Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Advanced analytics toolkit walkthrough for Terns Pharmaceuticals Inc.Portfolio Value Report & Real-Time Market Trend Scan - newser.com

Nov 02, 2025

Nov 02, 2025

What Wall Street predicts for Terns Pharmaceuticals Inc. stock priceM&A Rumor & Long-Term Safe Return Strategies - newser.com

Nov 02, 2025

Nov 02, 2025

What does recent volatility data suggest for Terns Pharmaceuticals Inc.Entry Point & Step-by-Step Swing Trade Plans - newser.com

Nov 02, 2025

Nov 01, 2025

Terns Pharmaceuticals Inc Stock Analysis and ForecastSwing Trading Watchlist & Today’s Picks, Tomorrow’s Winners - earlytimes.in

Nov 01, 2025